Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 18 studies | 55% ± 20% | |
oligodendrocyte precursor cell | 15 studies | 68% ± 22% | |
glutamatergic neuron | 11 studies | 37% ± 13% | |
smooth muscle cell | 11 studies | 34% ± 14% | |
pericyte | 8 studies | 39% ± 15% | |
endothelial cell | 8 studies | 26% ± 9% | |
GABAergic neuron | 6 studies | 43% ± 12% | |
cardiac muscle cell | 5 studies | 52% ± 13% | |
muscle cell | 3 studies | 47% ± 33% | |
granule cell | 3 studies | 69% ± 14% | |
oligodendrocyte | 3 studies | 27% ± 16% | |
interneuron | 3 studies | 31% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 2491.85 | 2607 / 2642 | 98% | 16.21 | 688 / 705 |
adrenal gland | 100% | 1204.75 | 258 / 258 | 90% | 4.78 | 206 / 230 |
lung | 98% | 1103.64 | 568 / 578 | 59% | 2.41 | 685 / 1155 |
esophagus | 80% | 3876.78 | 1163 / 1445 | 60% | 2.50 | 109 / 183 |
bladder | 76% | 909.52 | 16 / 21 | 37% | 0.91 | 186 / 504 |
intestine | 71% | 593.81 | 685 / 966 | 37% | 0.74 | 193 / 527 |
thymus | 74% | 542.23 | 485 / 653 | 23% | 0.47 | 142 / 605 |
kidney | 46% | 234.01 | 41 / 89 | 51% | 1.10 | 463 / 901 |
heart | 91% | 1361.51 | 782 / 861 | 0% | 0 | 0 / 0 |
skin | 17% | 71.22 | 311 / 1809 | 73% | 2.11 | 345 / 472 |
blood vessel | 88% | 944.55 | 1177 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 4.26 | 24 / 29 |
uterus | 59% | 361.62 | 100 / 170 | 23% | 0.82 | 104 / 459 |
stomach | 41% | 503.89 | 146 / 359 | 41% | 1.06 | 116 / 286 |
ovary | 36% | 262.39 | 64 / 180 | 42% | 2.37 | 181 / 430 |
adipose | 63% | 378.04 | 755 / 1204 | 0% | 0 | 0 / 0 |
breast | 55% | 266.07 | 252 / 459 | 6% | 0.12 | 70 / 1118 |
prostate | 44% | 324.69 | 108 / 245 | 12% | 0.23 | 60 / 502 |
muscle | 56% | 255.94 | 448 / 803 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0.88 | 1 / 328 | 44% | 0.77 | 78 / 178 |
spleen | 44% | 156.80 | 106 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 29% | 113.87 | 271 / 929 | 0% | 0 | 0 / 0 |
liver | 4% | 12.48 | 9 / 226 | 23% | 0.43 | 92 / 406 |
eye | 0% | 0 | 0 / 0 | 16% | 0.28 | 13 / 80 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.27 | 6 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
GO_0046339 | Biological process | diacylglycerol metabolic process |
GO_0090038 | Biological process | negative regulation of protein kinase C signaling |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0046486 | Biological process | glycerolipid metabolic process |
GO_0048666 | Biological process | neuron development |
GO_0030168 | Biological process | platelet activation |
GO_0046834 | Biological process | lipid phosphorylation |
GO_0050773 | Biological process | regulation of dendrite development |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005509 | Molecular function | calcium ion binding |
GO_0004143 | Molecular function | ATP-dependent diacylglycerol kinase activity |
GO_0008289 | Molecular function | lipid binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | DGKG |
Protein name | Diacylglycerol kinase gamma (DAG kinase gamma) (EC 2.7.1.107) (Diglyceride kinase gamma) (DGK-gamma) Diacylglycerol kinase (DAG kinase) (EC 2.7.1.107) Diacylglycerol kinase gamma |
Synonyms | DAGK3 |
Description | FUNCTION: Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids . Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (By similarity). Has no apparent specificity with regard to the acyl compositions of diacylglycerol . Specifically expressed in the cerebellum where it controls the level of diacylglycerol which in turn regulates the activity of protein kinase C gamma. Through protein kinase C gamma, indirectly regulates the dendritic development of Purkinje cells, cerebellar long term depression and ultimately cerebellar motor coordination (By similarity). . |
Accessions | ENST00000265022.8 [P49619-1] ENST00000382164.8 [P49619-3] H7C0L0 P49619 ENST00000344484.8 [P49619-2] ENST00000437018.2 Q2M589 |